2024-02-05 16:29 | CC:WBIO | WPD Pharmaceuticals Inc | | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2024-02-05 16:23 | CC:WBIO | WPD Pharmaceuticals Inc | | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2024-02-02 14:29 | CC:WBIO | WPD Pharmaceuticals Inc | | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2024-02-02 14:24 | CC:WBIO | WPD Pharmaceuticals Inc | | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2024-01-31 17:01 | CC:WBIO | WPD Pharmaceuticals Inc | | News Release200 | WPD Pharmaceuticals files 2021, 2022 results |
2023-11-01 13:42 | CC:WBIO | WPD Pharmaceuticals Inc | | News Release200 | WPD issues 13,524 WPD Poland shares to ACRX |
2023-09-08 12:48 | CC:WBIO | WPD Pharmaceuticals Inc | | News Release200 | WPD Pharma unit receives $1.3M from ACRX financing deal |
2023-09-01 17:24 | CC:WBIO | WPD Pharmaceuticals Inc | | News Release200 | WPD Pharma's Polish unit arranges financing with ACRX |
2023-08-09 17:28 | CC:WBIO | WPD Pharmaceuticals Inc | | News Release200 | WPD's Polish unit signs financing LOI with ACRX |
2023-06-15 14:51 | CC:WBIO | WPD Pharmaceuticals Inc | | News Release200 | WPD Pharmaceuticals closes $300,000 private placement |